REG - Sabien Technology - Issue of Equity
RNS Number : 0182PSabien Technology Group PLC14 October 2021THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.
14 October 2021
Sabien Technology Group plc
("Sabien" or the "Company")
Issue of Equity
Sabien has today issued 95,908 ordinary shares of 3 pence each ("Ordinary Shares") at 34.5 pence per Ordinary Share in settlement of an existing liability of £33,088 (the "New Shares"). Application will be made for the New Shares to be admitted to trading on AIM and admission is expected to become effective on 20 October 2021 ("Admission").
Following Admission, the Company will have 14,670,168 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any Ordinary Shares in Treasury. Following Admission, the figure of 14,670,168 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Further Information:
Sabien Technology Group plc
Richard Parris, Executive Chairman
+44 20 7993 3700
Allenby Capital Limited (Nominated Adviser)
John Depasquale / Nick Harriss / Vivek Bhardwaj
+44 20 3328 5656
Peterhouse Capital Limited (Broker)
Duncan Vasey / Lucy Williams
+44 20 7469 0930
The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.
A copy of this announcement will be available from the Company's website at www.sabien-tech.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDIOEDKNBQKBDBQKD
Recent news on Sabien Technology
See all newsREG - Sabien Technology - Director/PDMR Shareholding
AnnouncementREG - Sabien Technology - Holding(s) in Company
AnnouncementREG - Sabien Technology - Holding(s) in Company
AnnouncementREG - Sabien Technology - Holding(s) in Company
AnnouncementREG - Sabien Technology - Total Voting Rights
Announcement